AVALO THERAPEUTICS, INC. Inventory Write-down
AVALO THERAPEUTICS, INC. (AVTX) reported Inventory Write-down of $36.58 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2020-03-11
- AVALO THERAPEUTICS, INC. inventory write-down for fiscal 2019 was $36.58K, a 79.09% decline from fiscal 2018.
- AVALO THERAPEUTICS, INC. inventory write-down for fiscal 2018 was $174.94K, a 1.91% decline from fiscal 2017.
- AVALO THERAPEUTICS, INC. inventory write-down for fiscal 2017 was $178.35K.
- AVALO THERAPEUTICS, INC. inventory write-down for fiscal 2016 was $0.00.
| Period end | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|
| 2019-12-31 | $36.58K 10-K · filed 2020-03-11 | |
| 2018-12-31 | $174.94K 10-K · filed 2020-03-11 | $150.20K 10-K · filed 2019-03-18 |
| 2017-12-31 | $178.35K 10-K · filed 2019-03-18 | |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 | |
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |